New study shows spironolactone reduces heart failure hospitalizations, but not ... Eureka! Science News A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013 ... |
